These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15283213)

  • 21. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology.
    Aguado JM; Torre-Cisneros J; Fortún J; Benito N; Meije Y; Doblas A; Muñoz P
    Clin Infect Dis; 2009 May; 48(9):1276-84. PubMed ID: 19320593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gynecological issues after organ transplantation.
    Kaminski P; Bobrowska K; Pietrzak B; Bablok L; Wielgos M
    Neuro Endocrinol Lett; 2008 Dec; 29(6):852-6. PubMed ID: 19112398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infectious complications of solid organ transplantation.
    Poghosyan T; Ackerman SJ; Ravenel JG
    Semin Roentgenol; 2007 Jan; 42(1):11-22. PubMed ID: 17174171
    [No Abstract]   [Full Text] [Related]  

  • 24. Etiology and pathogenesis of tumors occurring after organ transplantation.
    Gruber SA; Matas AJ
    Transplant Sci; 1994 Sep; 4(1):87-104. PubMed ID: 7804702
    [No Abstract]   [Full Text] [Related]  

  • 25. Principles of antimicrobial therapy in the transplant recipient.
    de Pauw B; Rubin RH
    Transpl Infect Dis; 2007 Mar; 9(1):1-2. PubMed ID: 17313463
    [No Abstract]   [Full Text] [Related]  

  • 26. For organ transplant recipients, cancer threatens long-term survival.
    Ross K
    J Natl Cancer Inst; 2007 Mar; 99(6):421-2. PubMed ID: 17374827
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diabetes after transplantation].
    Durrbach A
    Nephrol Ther; 2006 May; 2 Suppl 3():S197-9. PubMed ID: 17370851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
    Végso G
    Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New-onset diabetes mellitus after solid organ transplantation.
    Bodziak KA; Hricik DE
    Transpl Int; 2009 May; 22(5):519-30. PubMed ID: 19040489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complications of immunosuppressive therapy in organ transplantation].
    Jørgensen KA; Dieperink H; Kirkegaard P
    Ugeskr Laeger; 2003 Dec; 165(49):4727-9. PubMed ID: 14708378
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of skin cancer in solid organ transplant recipients.
    Traywick C; O'Reilly FM
    Dermatol Ther; 2005; 18(1):12-8. PubMed ID: 15842608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
    Barba P; Piñana JL; Valcárcel D; Querol L; Martino R; Sureda A; Briones J; Delgado J; Brunet S; Sierra J
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1439-46. PubMed ID: 19822304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical analysis of infectious complications following abdominal cluster transplantation].
    Chen HX; Yin L; Peng CH; Zhou GW; Shen BY; Chen GM; Chen CQ; Zhou HJ; Li HW
    Zhonghua Wai Ke Za Zhi; 2007 Mar; 45(5):319-22. PubMed ID: 17535710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunosuppressive therapy and post-transplant malignancy.
    Domhan S; Zeier M; Abdollahi A
    Nephrol Dial Transplant; 2009 Apr; 24(4):1097-103. PubMed ID: 18978068
    [No Abstract]   [Full Text] [Related]  

  • 35. [Anesthesia following organ transplantation].
    Zalunardo MP
    Anaesthesist; 2000 Feb; 49(2):157-69. PubMed ID: 10756972
    [No Abstract]   [Full Text] [Related]  

  • 36. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the treatment and management of new-onset diabetes after transplantation.
    Wilkinson A; Davidson J; Dotta F; Home PD; Keown P; Kiberd B; Jardine A; Levitt N; Marchetti P; Markell M; Naicker S; O'Connell P; Schnitzler M; Standl E; Torregosa JV; Uchida K; Valantine H; Villamil F; Vincenti F; Wissing M
    Clin Transplant; 2005 Jun; 19(3):291-8. PubMed ID: 15877787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunosuppressive or surgical treatment for ocular Myasthenia Gravis.
    Chavis PS; Stickler DE; Walker A
    Arch Neurol; 2007 Dec; 64(12):1792-4. PubMed ID: 18071048
    [No Abstract]   [Full Text] [Related]  

  • 39. Dry-eye syndrome after allogeneic stem-cell transplantation in children.
    Fahnehjelm KT; Törnquist AL; Winiarski J
    Acta Ophthalmol; 2008 May; 86(3):253-8. PubMed ID: 18093259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment with sirolimus ameliorates tacrolimus-induced autoimmune cytopenias after solid organ transplant.
    Teachey DT; Jubelirer T; Baluarte HJ; Wade A; Manno CS
    Pediatr Blood Cancer; 2009 Dec; 53(6):1114-6. PubMed ID: 19621445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.